Yorktown Management & Research Company »

Tg Therapeutics shares owned by Yorktown Management & Research Company

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Yorktown Management & Research Company from 13F filings

Historical chart of Yorktown Management & Research Company investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Yorktown Management & Research Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Yorktown Management & Research Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $385k 11k 36.13
2025-06-30 $383k 11k 35.99

More positions owned by Yorktown Management & Research Company

iShares Convertible Bond ETF Conv Bd Etf (ICVT)
SPDR Bloomberg Barclays Convertible Securities ETF Bbg Conv Sec Etf (CWB)
Comfort Systems USA (FIX)
Ies Hldgs (IESC)
iShares US Preferred Stock ETF Pfd And Incm Sec (PFF)
CyberArk Software SHS (CYBR)
Axon Enterprise (AXON)
Robinhood Markets Com Cl A (HOOD)
Lpl Financial Holdings (LPLA)
Vanguard Emerging Markets Government Bond ETF Em Mk Gov Bd Etf (VWOB)
Mueller Industries (MLI)
Arista Networks Com Shs (ANET)
Fabrinet SHS (FN)
Insmed Com Par $.01 (INSM)
Sportradar Group Class A Ord Shs (SRAD)

View all positions for Yorktown Management & Research Company

Top funds holding Tg Therapeutics

BlackRock
Vanguard Group
State Street Corporation
ClearBridge Advisors
Soleus Capital Management
Geode Capital Management
Susquehanna International
Jane Street
Citadel Advisors
Pictet Asset Management Holding SA
Hood River Capital Management
Goldman Sachs Group
Northern Trust
Morgan Stanley
Charles Schwab Investment Management

View all funds holding Tg Therapeutics